Radiant Sage LLC, a provider of on-demand Clinical Trial Image Management solutions, today announced that it has partnered with one of the world's leading pharmaceutical companies to enhance and re-launch its open source DICOM images submitter solution, now named ImageLink. The significantly enriched tool will be a fully validated and supported open source solution that will enable clinical trial sponsors and their partners to submit and share images through one common user interface."During a clinical trial, image transfer between the sponsor and their partners can be a very cumbersome process as images and related data are captured and organized differently by the various acquirers. Our pharmaceutical partner realized the need for one open source solution that could be used by all of its partners which would enable images to be transmitted in a standardized format and organized to meet the specific clinical trial requirements," said Venkatesan Thangaraj, CEO and president at Radiant Sage. "Together, our objective is to turn the ImageLink tool into a valuable, validated and fully supported solution that will help drive its adoption rate rapidly among the potential end-user organizations."Through the partnership, the two organizations are integrating this tool as a plug-in to Radiant Sage's Corelab-in-a-Box(TM) and Image Collaborative Portal solutions. Radiant Sage will ensure the tool is authenticated by the necessary industry organizations, regularly update and maintain the solution, and serve as the technology provider to support end users. The open source model will also enable end users to further customize the application as desired and submit their changes back to the open source repository for others to share."We believe our current pharmaceutical partner will benefit immensely from having one common interface to use for its multiple vendors and from the adaptability and ease of integration of this open source tool," added Thangaraj. "Our longer-term vision is making this tool an industry standard so that all sponsors and vendors will have one, customizable tool for transmitting clinical image data organized in the required manner."
Subscribe to:
Post Comments (Atom)
Superhit News
-
US health regulator USFDA has issued a warning letter to German drug firm Fresenius Kabi AG for lapses at its drug manufacturing fac...
-
Goods and Service Tax (GST) is high on the agenda for the new government and its rollout is a priority. GST will benefit the Indian pharma...
-
Rib-X Pharmaceuticals, Inc. announced today the signature of an exclusive worldwide research collaboration agreement and option for license ...
-
Physiomics: Reports difficult trading but highlights growing interest from big pharmaceutical groupsPhysiomics ( LON:PYC ) said that trading conditions were difficult in the six months ended 31 December 2010, but it believes it is in a be...
-
Hindusthan National Glass and Industries Ltd is expected to finalize a strategic overseas acquisition in the pharmaceuticals space in the n...
-
The Minister of State (Health and Family Welfare), Sh Ashwini Kumar Choubey through a written reply in the Lok Sabha informed about th...
-
India's Central Drugs Standard Control Organization (CDSCO) has suspended the manufacturing of eye drops at the Chennai-based firm after...
-
The government is hoping to see the implementation of the track and trace system for domestic and export supply chain in another one y...
-
Diclofenac injection is a painkiller which is manufactured by Themis Medicare Ltd and marketed by Novartis India under the brand name ...
-
Amylin Pharmaceuticals, Inc. AMLN +16.15% and Alkermes plc ALKS +4.61% today announced that the U.S. Food and Drug Administration (FDA) has ...
No comments:
Post a Comment